1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vemurafenib in patients with relapsed refractory multiple myeloma harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study
    Journal Article

    Raje, N.; Chau, I.; Hyman, D. M.; Ribrag, V.; Blay, J. Y.; Tabernero, J.; Elez, E.; Wolf, J.; Yee, A. J.; Kaiser, M.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Donor-specific antibodies, immunoglobulin-free light chains, and BAFF levels in relation to risk of late-onset PTLD in liver recipients
    Journal Article

    Engels, E. A.; Jennings, L. W.; Everly, M. J.; Landgren, O.; Murata, K.; Yanik, E. L.; Pfeiffer, R. M.; Onaca, N.; Klintmalm, G. B.
    Transplantation Direct (2018)

    Fulltext@MSK | Save
  • Facilitating a culture of responsible and effective sharing of cancer genome data
    Book Section

    Siu, L. L.; Lawler, M.; Haussler, D.; Knoppers, B. M.; Lewin, J.; Vis, D. J.; Liao, R. G.; Andre, F.; Banks, I.; Barrett, J. C.; more...
    In Caplan, A. L.; Redman. B. K. (Eds.) Getting to Good: Research Integrity in the Biomedical Sciences (2018)

    Fulltext@MSK | Save
  • Clinical neurological features and electrographic patterns of patients with relapsed or refractory large B-cell lymphoma treated with axicabtagene ciloleucel at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Sequeira, A.; Mao, D.; Chen, X.; Avila, E.; Mead, E.; Sauter, C. S.; Palomba, M. L.; Dahi, P. B.; Batlevi, C. L.; Shah, G.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Tc17 cells mediate gut GVHD via IL-22 and dysbiosis
    Meeting Abstract

    Song, Q.; Wu, X.; Zeng, D.; Jenq, R. R.; Van den Brink, M. R. M.; Riggs, A. D.; Chen, Y.; Zeng, D.
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis
    Meeting Abstract

    Raffin, C.; Zhou, Y.; Piccoli, L.; Lanzavecchia, A.; Sadelain, M.; Tareen, S. U.; Fontenot, J. D.; Bluestone, J. A.
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • A delicate interplay between adaptive and innate immunity caused by immunotherapy triggers tumor immunity and aseptic inflammation
    Meeting Abstract

    Hirschhorn, D.; Ricca, J.; Gasmi, B.; DeHanau, O.; Mangarin, L. M.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • A global, randomized, placebo-controlled, phase 3 study of ibrutinib plus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (RCHOP) in patients with previously untreated non-germinal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Younes, A.; Sehn, L. H.; Johnson, P.; Zinzani, P. L.; Hong, X.; Zhu, J.; Samoilova, O.; Suh, C.; Matsumura, I.; Lopez-Hernandez, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Ball, B.; Famulare, C.; Pastore, F.; Tallman, M. S.; Zhang, Y.; Arcila, M. E.; Papaemmanuil, E.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save